Tissue accumulation of cephalothin in burns: A comparative study by microdialysis of subcutaneous interstitial fluid cephalothin concentrations in burn patients and healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 1, 2009, Pages 210-215

  Dalley, Andrew J ^a,d   Lipman, Jeffrey ^a,b   Deans, Renae ^a,b   Venkatesh, Bala ^c   Rudd, Michael ^b   Roberts, Michael S ^a   Cross, Sheree E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALOTIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BIOACCUMULATION; BURN; BURN PATIENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HUMAN; INTERSTITIAL FLUID; MICRODIALYSIS; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; SURGICAL PATIENT;

ADULT; BURNS; CEPHALOTHIN; EXTRACELLULAR FLUID; HUMANS; MICRODIALYSIS; SUBCUTANEOUS TISSUE;

EID: 59749090293     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00718-08     Document Type: Article

References (23)

1. Bouw, M. R., and M. Hammarlund-Udenaes. 1998. Methodological aspects of the use of a calibrator in in vivo microdialysis - further development of the retrodialysis method. Pharm. Res. 15:1673-1679.
2. Chaurasia, C. S., M. Muller, E. D. Bashaw, E. Benfeldt, J. Bolinder, R. Bullock, P. M. Bungay, E. C. M. DeLange, H. Derendorf, W. F. Elmquist, M. Hammarlund-Udenaes, C. Joukhadar, D. L. Kellogg, C. E. Lunte, C. H. Nordstrom, H. Rollema, R. J. Sawchuk, B. W. Y. Cheung, V. P. Shah, L. Stahle, U. Ungerstedt, D. F. Welty, and H. Yeo. 2007. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm. Res. 24:1014-1025.
3. Cross, K. M., L. Leonardi, J. R. Payette, M. Gomez, M. A. Levasseur, B. J. Schattka, M. G. Sowa, and J. S. Fish. 2007. Clinical utilization of near-infrared spectroscopy devices for burn depth assessment. Wound Repair Regen. 15:332-340.
4. Dalley, A. J., J. Lipman, B. Venkatesh, M. Rudd, M. S. Roberts, and S. E. Cross. 2007. Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement. J. Antimicrob. Chemother. 60:166-169.
5. Demling, R. H. 2005. The burn edema process: current concepts. J. Burn Care Rehabil. 26:207-227.
6. Dulhunty, J. M., R. J. Boots, M. J. Rudd, M. J. Muller, and J. Lipman. 2008. Increased fluid resuscitation can lead to adverse outcomes in major-burn injured patients, but low mortality is achievable. Burns 34:1090-1097.
7. Han, T. H., J. S. Harmatz, D. J. Greenblatt, and J. A. J. Martyn. 2007. Fentanyl clearance and volume of distribution are increased in patients with major burns. J. Clin. Pharmacol. 47:674-680.
8. Han, T. H., J. H. Lee, I. S. Kwak, H. Y. Kil, K. W. Han, and K. M. Kim. 2005. The relationship between bispectral index and targeted propofol concentration is biphasic in patients with major burns. Acta Anaesthesiol. Scand. 49:85-91.
9. Jaehde, U., and F. Sörgel. 1995. Clinical pharmacokinetics in patients with burns. Clin. Pharmacokinet. 29:15-28.
10. Lin, J. H. 2006. Tissue distribution and pharmacodynamics: a complicated relationship. Curr. Drug Metab. 7:39-65.
11. Lund, T., H. Onarheim, and R. K. Reed. 1992. Pathogenesis of edema formation in burn injuries. World J. Surg. 16:2-9.
12. Macfie, A. G., A. D. Magides, and C. S. Reilly. 1992. Disposition of alfentanil in burns patients. Br. J. Anaesth. 69:447-450.
13. Muller, M., A. D. Pena, and H. Derendorf. 2004. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue. Antimicrob. Agents Chemother. 48:1441-1453.
14. Papini, R. P., A. P. R. Wilson, J. A. Steer, G. Hill, D. A. McGrouther, and N. Parkhouse. 1997. Plasma concentrations of tumour necrosis factor-alpha and interleukin-6 during burn wound surgery or dressing. Br. J. Plast. Surg. 50:354-361.
15. Pea, F., P. Viale, and M. Furlanut. 2005. Antimicrobial therapy in critically ill patients - a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability. Clin. Pharmacokinet. 44:1009-1034.
16. Pinder, M., R. Bellomo, and J. Lipman. 2002. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth. Intensive Care 30:134-144.
17. Samuelsson, A., I. Steinvall, and F. Sjöberg. 2006. Microdialysis shows metabolic effects in skin during fluid resuscitation in burn-injured patients. Crit. Care 10:R172.
18. Vicente, M. V., T. Olay, M. C. R. Quecedo, and A. Rodriguez. 1979. Diffusion of beta-lactam antibiotics and fosfomycin to interstitial-tissue fluid in rabbits. Chemotherapy 25:329-335.
19. Victorian Drug Usage Advisory Committee. 2006. Therapeutic guidelines: antibiotic, 13th ed. Victorian Drug Usage Advisory Committee, Melbourne, Australia.
20. Vlachou, E., P. Gosling, and N. S. Moiemen. 2008. Microalbuminuria: a marker of systemic endothelial dysfunction during burn excision. Burns 34:241-246.
21. Walstad, R. A., L. Aanderud, and E. Thurmann-Nielsen. 1988. Pharmacokinetics and tissue concentrations of ceftazidime in burn patients. Eur. J. Clin. Pharmacol. 35:543-549.
22. Weinbren, M. J. 1999. Pharmacokinetics of antibiotics in burn patients. J. Antimicrob. Chemother. 44:319-327.
23. Williams, J. D., and F. Moosdeen. 1987. In-vitro antibacterial effects of cephalosporins. Drugs 34:44-63.